References
- Surdacki A. L-arginine analogs – inactive markers or active agents in atherogenesis? Cardiovasc Hematol Agents Med Chem 2008;6:302–11.
- Surdacki A, Martens-Lobenhoffer J, Wloch A, Marewicz E, Rakowski T, Wieczorek-Surdacka E, . Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2007;56:809–19.
- Surdacki A, Martens-Lobenhoffer J, Wloch A, Gluszko P, Rakowski T, Dubiel JS, . Plasma asymmetric dimethylarginine is related to anticitrullinated protein antibodies in rheumatoid arthritis of short duration. Metabolism 2009;58:316–18.
- Turiel M, Atzeni F, Tomasoni L, de Portu S, Delfino L, Bodini BD, . Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. Rheumatology 2009;48:834–9.
- Lopez-Longo FJ, Oliver-Minarro D, de la Torre I, Gonzalez-Díaz de Rabago E, Sanchez-Ramon S, Rodríguez-Mahou M, . Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum 2009;61:419–24.
- Gonzalez A, Icen M, Kremers HM, Crowson CS, Davis JM 3rd, Therneau TM, . Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol 2008;35:1009–14.
- Tomasson G, Aspelund T, Jonsson T, Valdimarsson H, Felson DT, Gudnason V. The effect of rheumatoid factor on mortality and coronary heart disease. Ann Rheum Dis 2010;69:1649–54.
- Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, . Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med 2004;42:1377–83.
- Bultink IE, Teerlink T, Heijst JA, Dijkmans BAC, Voskuyl AE. Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus. Ann Rheum Dis 2005;64:1362–5.
- Sun K-H, Tang S-J, Wang Y-S, Lin W-J, You R-I. Autoantibodies to dsDNA cross-react with the arginine-glycine-rich domain of heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) and promote methylation of hnRNP A2. Rheumatology 2003;42:154–61.
- Hannestad K, Johannessen A. Polyclonal human antibodies to IgG (rheumatoid factors) which cross-react with cell nuclei. Scand J Immunol 1976;5:541–7.
- Kato H, Yamakawa M, Ogino T. Complement mediated vascular endothelial injury in rheumatoid nodules: a histopathological and immunohistochemical study. J Rheumatol 2000;27:1839–47.